Where can I buy ear shares?
Shares of EAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Does Eargo have a dividend growth track record?
Eargo does not have a long track record of dividend growth. In the past three months, Eargo insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $16,975.00 in company stock. 15.54% of the stock of Eargo is held by insiders.
Who sold earear stock in the last quarter?
EAR stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Bank of America Corp DE, Susquehanna International Group LLP, Citadel Advisors LLC, Squarepoint Ops LLC, Blair William & Co. IL, Deutsche Bank AG, and Commonwealth Equity Services LLC.
What happened with the ear IPO?
(EAR) raised $100 million in an initial public offering on Friday, October 16th 2020. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. J.P.Morgan and BofA Securities served as the underwriters for the IPO and Wells Fargo Securities and William Blair were co-managers.
Is EAR a good stock to buy?
Out of 3 analysts, 0 (0%) are recommending EAR as a Strong Buy, 0 (0%) are recommending EAR as a Buy, 2 (66.67%) are recommending EAR as a Hold, 0 (0%) are recommending EAR as a Sell, and 1 (33.33%) are recommending EAR as a Strong Sell.
Why did Eargo stock drop today?
What happened. Shares of Eargo (NASDAQ: EAR), a hearing aid manufacturer, are sinking in response to the disclosure of a federal investigation the company made to investors after markets closed on Wednesday. The medical device stock was down 68.5% as of 10:40 a.m. EDT on Thursday.
Is Eargo a good investment?
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Eargo with a $61.00 average price target.
Who manufactures Eargo?
Eargo is an American hearing aid manufacturer based in San Jose, California....Eargo.TypePublicArea servedUnited StatesKey peopleChristian Gormsen (President, CEO, and Director)ProductsHearing aidsRevenue$45 million (2020)6 more rows
Should I buy or sell Eargo stock right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eargo in the last year. There are currently 1 sell rating and 2 hold ratin...
What is Eargo's stock price forecast for 2022?
3 analysts have issued 12 month price targets for Eargo's stock. Their forecasts range from $10.00 to $11.00. On average, they predict Eargo's stoc...
How has Eargo's stock price performed in 2022?
Eargo's stock was trading at $5.10 at the start of the year. Since then, EAR shares have decreased by 75.5% and is now trading at $1.25. View the...
When is Eargo's next earnings date?
Eargo is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Eargo .
How were Eargo's earnings last quarter?
Eargo, Inc. (NASDAQ:EAR) issued its quarterly earnings data on Tuesday, May, 24th. The company reported ($0.78) EPS for the quarter. The company ha...
Who are Eargo's key executives?
Eargo's management team includes the following people: Mr. Christian Gormsen , CEO, Pres & Director (Age 46, Pay $662.17k) Mr. Adam Laponis , C...
Who are some of Eargo's key competitors?
Some companies that are related to Eargo include Sanara MedTech (SMTI) , Lakeland Industries (LAKE) , United Health Products (UEEC) , Sientra (...
When did Eargo IPO?
(EAR) raised $100 million in an initial public offering (IPO) on Friday, October 16th 2020. The company issued 6,700,000 shares at a price of $14.0...
What is Eargo's stock symbol?
Eargo trades on the NASDAQ under the ticker symbol "EAR."
When will Eargo update its earnings?
How much does Eargo make?
Eargo updated its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided EPS guidance of $- for the period. The company issued revenue guidance of $89 million-93 million, compared to the consensus revenue estimate of $90.06 million.
How to contact Eargo by phone?
The company earns $-39,850,000.00 in net income (profit) each year or ($3.80) on an earnings per share basis.
What is the rating of Eargo?
The company can be reached via phone at 650-351-7700 or via email at [email protected].
What is Eargo hearing aids?
Eargo has received a consensus rating of Hold. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.
Does Eargo pay dividends?
Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.
Who rated Eargo?
Eargo does not currently pay a dividend.
How does MarketBeat calculate stock ratings?
Eargo has been rated by JPMorgan Chase & Co., Wells Fargo & Company, and William Blair in the past 90 days.
What is Eargo hearing aid?
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
What is market cap?
Eargo Inc is a medical device company, focused on improving the quality of life of people with hearing loss. The company offers hearing aids, professional support services, and other insurance-related services. The product portfolio includes Eargo Neo HiFi, Eargo Neo, Eargo Max, and related accessories.
What is Eargo hearing aid?
Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
Does Morningstar cover ratings?
Eargo Inc is a medical device company, focused on improving the quality of life of people with hearing loss. The company offers hearing aids, professional support services, and other insurance-related services. The product portfolio includes Eargo Neo HiFi, Eargo Neo, Eargo Max, and related accessories.